Role of imaging biomarkers in mutation-driven non-small cell lung cancer

Lung cancer remains the leading cause of cancer-related deaths worldwide. The treatment of non-small cell lung cancer (NSCLC), which accounts for a vast majority of lung cancers, has shifted to personalized, targeted therapy following discoveries of several targetable oncogenic mutations. Targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendoza, Dexter P, Piotrowska, Zofia, Lennerz, Jochen K, Digumarthy, Subba R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407925/
https://www.ncbi.nlm.nih.gov/pubmed/32821649
http://dx.doi.org/10.5306/wjco.v11.i7.412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407925/
https://www.ncbi.nlm.nih.gov/pubmed/32821649
http://dx.doi.org/10.5306/wjco.v11.i7.412

Ejemplares similares